| Application no. and date | 13749171.8 (espacenet) (Federated) (European Patent Register), 20130214 | | Patent/reg. no. and date | DK/EP 2815753, 20180516 | | Publication date | 20141224 | | Priority no. and date | JP 2012031143, 20120215 | | EP pub. no. and date |
EP 2815753 20141224 | | Effective date | | | Applicant/owner | Taiho Pharmaceutical Co., Ltd., 1-27, Kandanishiki-cho
Chiyoda-ku, Tokyo 101-8444, JP | | Applicant ref. no. | P87345DK01 | | Inventor | OHNISHI, Yoshito, c/o Taiho Pharmaceutical Co., Ltd.,
224-2, Hiraishiebisuno,
Kawauchi-cho,
Tokushima-shi,
Tokushima 771-0194, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61K 31/7072 (2006.01) , A61K 47/10 (2017.01) , A61K 47/26 (2006.01) , A61K 47/32 (2006.01) , A61K 47/36 (2006.01) , A61K 47/38 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) | | Title | ORALT ADMINISTRERBAR FARMACEUTISK SAMMENSÆTNING OMFATTENDE A,A,A-TRIFLUORTHYMIDIN OG 5-CHLOR-6-(2-IMINOPYRROLIDIN-1-YL)METHYL-2,4 (1H,3H)-PYRIMIDINDIONHYDROCHLORID | | Int. application no. | JP2013053513 | | Int. publication no. | WO2013122134 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
